Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px
Document › Details

Promethera Biosciences S.A.. (1/5/16). "Press Release: Promethera Biosciences to Be Present at J.P. Morgan Healthcare Conference 2016".

Region Region San Francisco, CA
  Country United States (USA)
Organisations Organisation Promethera Biosciences S.A.
  Group Promethera (Group)
  Organisation 2 J.P. Morgan Investment Management Inc.
  Group JPMorgan Chase (Group)
Products Product J.P. Morgan 34th Annual Healthcare Conference 2016 San Francisco
  Product 2 cell therapy
Index term Index term Promethera–JPMorgan Chase: investor conference, 201601 supply service Promethera attends JP Morgan Healthcare Conference 2016
Persons Person Tchelingerian, John (Promethera 201509– CEO before Silver Ocean Ventures + Neurotech + Diatos)
  Person 2 Hazevoets, Frank (Promethera Biosciences 201601 CFO + Head of Corporate Development LEFT 10/18)

Promethera Biosciences will be participating to the 34th edition of the annual J.P. Morgan Healthcare Conference which will be held from 11 to 15 January 2016 in San Francisco.

The J.P. Morgan Healthcare conference is the biggest healthcare investment event and attracts a broad range of analysts and institutional investors.

John Tchelingerian - CEO, and Frank Hazevoets - CFO and Head Corporate Development - will be present to meet with investors and potential partners and share with them Promethera's strategic vision for future developments.

Record changed: 2017-07-02


Picture [LSA] – The Business Web Portal 650x89px

More documents for Promethera (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px

» top